Restrictions on the reimbursement of ginkgo biloba preparations to be eased

Published: 2008-04-11 06:58:00

Updated: 2008-04-11 06:58:00

Standards for reimbursing ginkgo biloba preparations, such as SK Chemical’s Ginexin and Yuyu’s Tanamin, announced on January 1 are expected to be eased sometime next month, according to informed sources.

The public notice that the reimbursement of ginkgo biloba preparations would be limited t...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK